Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Systemic Immunity Is Required for Effective Cancer Immunotherapy.

Cell | 2017

Immune responses involve coordination across cell types and tissues. However, studies in cancer immunotherapy have focused heavily on local immune responses in the tumor microenvironment. To investigate immune activity more broadly, we performed an organism-wide study in genetically engineered cancer models using mass cytometry. We analyzed immune responses in several tissues after immunotherapy by developing intuitive models for visualizing single-cell data with statistical inference. Immune activation was evident in the tumor and systemically shortly after effective therapy was administered. However, during tumor rejection, only peripheral immune cells sustained their proliferation. This systemic response was coordinated across tissues and required for tumor eradication in several immunotherapy models. An emergent population of peripheral CD4 T cells conferred protection against new tumors and was significantly expanded in patients responding to immunotherapy. These studies demonstrate the critical impact of systemic immune responses that drive tumor rejection.

Pubmed ID: 28111070 RIS Download

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: T32 CA009302
  • Agency: NCI NIH HHS, United States
    Id: R33 CA183654
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI118884
  • Agency: NCI NIH HHS, United States
    Id: F31 CA189331
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI057229
  • Agency: NIH HHS, United States
    Id: DP5 OD023056
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI100627
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL120724
  • Agency: NIAID NIH HHS, United States
    Id: HHSN272201200028C
  • Agency: NCI NIH HHS, United States
    Id: U54 CA209971
  • Agency: NCI NIH HHS, United States
    Id: F32 CA189408
  • Agency: NCI NIH HHS, United States
    Id: R01 CA196657

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


InVivoPlus anti-mouse PD-1 (CD279) (antibody)

RRID:AB_10949053

This monoclonal targets PD-1 (CD279)

View all literature mentions

InVivoPlus anti-mouse PD-L1 (B7-H1) (antibody)

RRID:AB_10949073

This monoclonal targets PD-L1 (B7-H1)

View all literature mentions

InVivoPlus anti-mouse CD40 (antibody)

RRID:AB_1107647

This monoclonal targets CD40

View all literature mentions

MC-38 (cell line)

RRID:CVCL_B288

Cell line MC-38 is a Cancer cell line with a species of origin Mus musculus

View all literature mentions

4T1 (cell line)

RRID:CVCL_0125

Cell line 4T1 is a Cancer cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

FVB/N-Tg(MMTV-PyVT)634Mul/J (organism)

RRID:IMSR_JAX:002374

Mus musculus with name FVB/N-Tg(MMTV-PyVT)634Mul/J from IMSR.

View all literature mentions

B6.Cg-Tg(Tyr-cre/ERT2)13Bos Braftm1Mmcm Pten/BosJ (organism)

RRID:IMSR_JAX:013590

Mus musculus with name B6.Cg-Tg(Tyr-cre/ERT2)13Bos Braftm1Mmcm Pten/BosJ from IMSR.

View all literature mentions

Gephi (data processing software)

RRID:SCR_004293

Open-source software for network visualization and analysis helping data analysts to intuitively reveal patterns and trends, highlight outliers and tells stories with their data. It uses a 3D render engine to display large graphs in real-time and to speed up the exploration. Gephi combines built-in functionalities and flexible architecture to: explore, analyze, spatialize, filter, cluterize, manipulate and export all types of networks. Gephi runs on Windows, Linux and Mac OS X. Gephi is based on a visualize-and-manipulate paradigm which allow any user to discover networks and data properties. Moreover, it is designed to follow the chain of a case study, from data file to nice printable maps. It is open-source and free (GNU General Public License). Applications: * Exploratory Data Analysis: intuition-oriented analysis by networks manipulations in real time. * Link Analysis: revealing the underlying structures of associations between objects, in particular in scale-free networks. * Social Network Analysis: easy creation of social data connectors to map community organizations and small-world networks. * Biological Network analysis: representing patterns of biological data. * Poster creation: scientific work promotion with hi-quality printable maps. Gephi 0.7 architecture is modular and therefore allows developers to add and extend functionalities with ease. New features like Metrics, Layout, Filters, Data sources and more can be easily packaged in plugins and shared. The built-in Plugins Center automatically gets the list of plugins available from the Gephi Plugin portal and takes care of all software updates. Download, comment, and rate plugins provided by community members and third-party companies, or post your own contributions!

View all literature mentions

MC-38 (cell line)

RRID:CVCL_B288

Cell line MC-38 is a Cancer cell line with a species of origin Mus musculus

View all literature mentions

MC-38 (cell line)

RRID:CVCL_B288

Cell line MC-38 is a Cancer cell line with a species of origin Mus musculus

View all literature mentions